Selling biological reagents is truly difficult: Reflections on breaking through under homogeneous competition.

The customer decision-making chain has lengthened: from "buying reagents" to "buying solutions"

In the past, biological reagent sales were often understood as catalog-based quoting, ordering, and shipping. However, the needs of current research users and industrial customers have shifted from single products to complete technical support and experimental validation. Taking commonly used polymerases, reverse transcriptases, antibodies, and cell culture supplements in molecular biology as examples, customers before placing an order not only focus on product performance parameters but also evaluate batch-to-batch consistency, applicable sample types, compatibility with matching buffers, and the response depth of after-sales technical support. If salespeople remain only at the level of price and lead time, it is difficult for them to enter the customer's shortlist. Some customers will request small-package trial samples, reference experimental protocols, and even invite suppliers to jointly complete preliminary experiments. This type of pre-sales work has a long cycle and uncertain results, making the traditional "order-chasing" model difficult to sustain.

At the same time, the procurement rhythms of different institutions differ significantly. University research groups are often affected by funding execution milestones and graduate student graduation schedules, with procurement needs concentrated in certain months; biopharmaceutical companies pay more attention to supplier audits, quality agreements, and long-term supply stability. Salespeople need to understand these decision milestones and role divisions; otherwise, it is easy to lose an order after months of follow-up due to laboratory relocation, changes in research direction, or budget freezes. A decision-making process involving multiple milestones and multiple roles significantly increases the cost of maintaining each customer and also makes sales forecasting more difficult.

Compliance and quality control raise hidden costs

The quality of biological reagents is directly related to the reproducibility of experimental results, so purchasers have increasingly detailed requirements for compliance documents. Quality inspection reports for common specifications, stability data, animal-derived statements, MSDS, and other documents have become basic thresholds. For in vitro diagnostic reagent raw materials or pharmaceutical excipient-grade biological raw materials, customers may also require suppliers to cooperate in completing change notifications, deviation investigations, and on-site audits. These tasks are not covered by traditional sales functions, yet they directly affect whether an order can be finalized. Salespeople must coordinate with quality, production, and regulatory departments to complete documents and processes; otherwise, even if product performance is recognized, the order may still be stuck at the compliance stage.

Compliance requirements also increase time costs. An ordinary research order may only require comparing parameters and prices, but when industrial customers are involved, from supplier qualification to first supply often takes several weeks or even longer. During the waiting period, salespeople still need to maintain technical communication and help customers solve detailed issues in experimental design. This characteristic of "sales upfront, delivery later" places higher demands on the professional accumulation and patience of practitioners in biological reagent sales.

Payment collection cycles and inventory management pressures coexist

Another difficulty in biological reagent sales lies in funds and inventory. Many universities and research institutions have long payment processes, and some corporate customers also negotiate payment terms, resulting in a time gap between sales collection and actual delivery. If salespeople stock up heavily to meet performance targets, they may also face loss risks caused by approaching expiration dates and changes in storage conditions. Taking enzymes, antibodies, and recombinant proteins as examples, cold-chain transportation and low-temperature storage are generally required, and any slight carelessness in inventory turnover can cause losses. Therefore, salespeople need to find a balance among customer demand forecasting, stocking strategy, and payment term management, and cannot focus only on order amount.

Inventory pressure can also backfire on customer trust. If stockouts occur due to insufficient stocking, customers' experimental progress is hindered; if excessive stocking leads to scattered batch numbers or shipment of near-expiry products, quality complaints may be triggered. Experienced salespeople will communicate usage plans with customers in advance and provide suggestions based on common ordering cycles and manufacturers' production cycles, avoiding simply shifting inventory risk to either party. This refined operational capability is often the hardest for newcomers to master in a short period.

Technical service capability becomes a dividing line

A significant difference between biological reagent sales and ordinary industrial product sales is that customers may need professional answers before, during, and after purchase. For example, customers will ask whether a certain antibody is suitable for immunoprecipitation, immunofluorescence, or flow cytometry, or how a certain reverse transcriptase performs in amplifying high-GC templates. If such questions cannot be answered promptly and accurately, customers can easily turn to other suppliers. If salespeople lack a foundation in molecular biology or immunology, they can only repeatedly relay the opinions of technical support, communication efficiency will decline markedly, and it will be difficult to build professional trust.

Therefore, more and more companies tend to recruit personnel with relevant experimental backgrounds or industry experience when hiring biological reagent salespeople. But this does not mean that salespeople must be proficient in all experiments; rather, they need to understand customers' experimental goals and key variables, know when to bring in technical support, and how to organize internal resources.The ability to translate "sales language" into "experimental language" and then bring customer feedback back to R&D and quality departments—this bridging role is precisely the core value of a professional salesperson.

Breaking the deadlock: shifting from pitching to professional consulting

Faced with the above difficulties, the path of relying solely on price competition or relationship marketing has become increasingly narrow. A more viable direction for bioreagent sales is to become an external consultant within the customer's experimental workflow. Specifically, one can start by mapping out customer application scenarios, distinguishing between different needs such as basic research, process development, and quality release, and then matching products and services at the corresponding level. For example, basic research may place greater emphasis on flexibility and technical support, while industrial customers place greater emphasis on batch consistency and supply security. During the first visit, salespeople who talk less about product parameters and learn more about the experimental bottlenecks customers are currently facing are more likely to secure opportunities for follow-up communication.

In addition, building a personal knowledge base is also essential. Organizing common technical questions, competitive comparison approaches, and lessons learned from failures in customer cases into a compendium, and regularly reviewing the reasons for lost deals, can help gradually improve follow-up efficiency. The difficulty of bioreagent sales is an industry consensus, but difficulty also means competitive barriers created by professional thresholds. Those willing to continuously invest in technical understanding, compliance awareness, and customer accompaniment often develop a stable customer base after long-term accumulation.